Plus   Neg

Stock Alert: BioNTech Shares Up 7%

Shares of BioNTech SE (BNTX) are rising over 7% Monday morning, after the company and Pfizer Inc. (PFE) announced early positive update from German Phase 1/2 COVID-19 vaccine study, including first T cell response data.

The preliminary clinical results are for the most advanced investigational vaccine candidate in Pfizer's and BioNTech's BNT162 mRNA-based vaccine program against SARS-CoV-2, BNT162b1.

The stock has been trading in the range of $12.52 - $105.00 for the past one year, and is currently trading at $91.32, up $6.07 or 7.13% in the regular session Monday.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT